Halaman 2 - Kemoterapi untuk kanker ovarium Dokter Terbaik - TOP-36 dokter

Profesor Asosiasi Atakan Topcu berspesialisasi dalam kemoterapi kanker ovarium dengan fokus pada terapi target dan imunoterapi di Rumah Sakit Distrik Medipol Acibadem.

• Telah menerbitkan lebih dari 50 artikel ilmiah di bidang onkologi
• Anggota Masyarakat Eropa untuk Onkologi Medis (ESMO)
• Pakar dalam onkologi geriatri dan malnutrisi terkait kanker
• Terlatih melalui program fellowship di bidang onkologi medis di Universitas Bezmialem Vakıf

Prof. Madya Nail Paksoy berspesialisasi dalam kemoterapi kanker ovarium di Rumah Sakit Medipol Bahçelievler, dengan sertifikasi ESMO dan partisipasi aktif dalam uji klinis.

• Penelitian yang diterbitkan tentang desensitisasi karboplatin untuk kanker ovarium
• Subinvestigator dalam uji coba kanker ovarium ENGOT-ov43/GOG-3036
• Fellowship onkologi medis di Institut Onkologi Universitas Istanbul
• Tersertifikasi Dewan ESMO dalam Onkologi Medis

Profesor Madya Onkologi Medis di İstinye University Liv Hospital Topkapı, berspesialisasi dalam kemoterapi untuk kanker ovarium.

• 18+ tahun dalam praktik medis dengan fokus pada onkologi
• Menerbitkan 19 artikel yang ditinjau sejawat mengenai berbagai perawatan kanker
• Anggota American Society of Clinical Oncology (ASCO) dan Turkish Society of Medical Oncology
• Koordinator Pendidikan untuk Sub-Cabang Onkologi Medis di Prof. Dr. Cemil Taşcıoğlu City Hospital

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Shruti Kate berspesialisasi dalam kanker ginekologi, dengan keahlian dalam imunoterapi dan terapi metronomik untuk kasus-kasus lanjut. Beliau menempuh pendidikan di Tata Memorial Hospital – pusat kanker terkemuka di India.

• DM dalam Onkologi Medis dari Tata Memorial Hospital
• Anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
• Mempresentasikan penelitian kanker paru-paru di Konferensi Dunia tentang Kanker Paru-paru
• Keahlian dalam tumor padat dan keganasan hematologi

Lebih dari 50.000 operasi kanker selama 19 tahun – Dr. Nagarkar menempuh pendidikan di Tata Memorial Hospital dan berspesialisasi dalam Onkologi Bedah Payudara dan Toraks.

• Melakukan 200+ uji klinis fase 1-3 untuk memajukan pengobatan kanker
• Profesor untuk subspesialisasi DNB Onkologi Bedah (Delhi National Board)
• Mendirikan Curie Manavata Cancer Centre pada tahun 2007
• Berfokus pada peningkatan kualitas hidup pasien di samping pengobatan

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Shaunak Valame berspesialisasi dalam terapi target untuk kanker ovarium, dengan penelitian yang dipresentasikan di Gastrointestinal Cancer Symposium yang elit.

• DNB dalam Onkologi Medis dari Indraprastha Apollo Hospital
• Keahlian dalam dasar molekuler kanker
• Mempresentasikan penelitian tentang kanker lambung di ASCO
• Residensi Senior di Shyam Shah Medical College

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Lalit telah melakukan lebih dari 10.000 operasi besar, berspesialisasi dalam operasi kanker invasif minimal dengan hasil yang sangat baik di HCG Manavata Cancer Centre.

• Pelatihan Fellowship dalam Onkologi Bedah di Tata Medical Centre, Kolkata
• Fokus khusus pada operasi kanker gastrointestinal
• Co-peneliti utama dalam berbagai studi penelitian orisinal
• Mantan Asisten Profesor di State Cancer Institute, Aurangabad
• Dikenal karena pendekatan yang etis dan ramah pasien

Dr. Ahmer Arif Shaikh berspesialisasi dalam onkologi bedah dengan fokus pada kanker mulut, pelestarian organ, dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 3 tahun pengalaman dalam onkologi bedah
• Keahlian dalam bedah maksilofasial serta kepala & leher utama
• Pelatihan fellowship dalam Onkologi Bedah Kepala & Leher
• Peneliti dengan berbagai publikasi

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde berspesialisasi dalam kedokteran nuklir di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir dan onkologi
• Mahir dalam terapi radioiodine dan Lu-177 RN
• Terampil dalam pemindaian PET-CT dan layanan kardiologi nuklir
• Menerbitkan berbagai makalah di jurnal medis

Dr. Sridhar P.S. berspesialisasi dalam radioterapi dan kemoterapi untuk kanker ovarium di HCG Manavata Cancer Centre.

• Pengalaman lebih dari 20 tahun di bidang onkologi
• Diplomate of National Board dalam radioterapi
• Anggota Association of Radiation Oncology of India
• Bagian dari Bangalore Oncology Group